A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia
暂无分享,去创建一个
A. Ganser | G. Papa | J. Szer | M. Sanz | G. Heil | K. Lechner | D. Hoelzer | J. Matcham | L. Noens | C. O'brien | J. Yin | A. Barge | J. L. Liu Yin | Miguel A Sanz | Giuseppe Papa | Luc Noens | James Matcham | Alan Barge
[1] B. Löwenberg,et al. Application of myeloid growth factors in the treatment of acute myeloid leukemia , 1997, Leukemia.
[2] J. Rowe,et al. Hematopoietic growth factors in acute leukemia , 1997, Leukemia.
[3] W. Hiddemann,et al. Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects. , 1997, Seminars in oncology.
[4] C. Schiffer. Hematopoietic growth factors as adjuncts to the treatment of acute myeloid leukemia. , 1996, Blood.
[5] F. Mandelli,et al. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] F. D. de Sauvage,et al. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin , 1996, The Journal of experimental medicine.
[7] J. Bennett,et al. A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). , 1995, Blood.
[8] Stephen L. George,et al. Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia , 1995 .
[9] R. Bouabdallah,et al. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. , 1995, The New England journal of medicine.
[10] N. Schmitz,et al. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. , 1995, Bone marrow transplantation.
[11] R. Mertelsmann,et al. GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). , 1995, Leukemia.
[12] F. Grant,et al. Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. C. Hu,et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor MpI , 1994, Cell.
[14] D. Goeddel,et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand , 1994, Nature.
[15] D. Metcalf. Thrombopoietin — at last , 1994, Nature.
[16] Masahiro Yoshida,et al. A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Kohseisho Leukemia Study Group [see comments] , 1994 .
[17] R. Mayer,et al. The approach to the elderly patient with acute myeloid leukemia. , 1993, Hematology/oncology clinics of North America.
[18] I. Touw,et al. Hematopoietic growth factors and their receptors in acute leukemia. , 1993, Blood.
[19] C. Tangen,et al. A Southwest Oncology Group study , 1993 .
[20] J. von Pawel,et al. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. , 1993, European journal of cancer.
[21] J. Radford,et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. , 1992, Blood.
[22] M. Kris,et al. Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer , 1991 .
[23] E. Wagner,et al. Expression of human CSF-1 receptor induces CSF-1-dependent proliferation in murine myeloid but not in T-lymphoid cells. , 1991, Leukemia.
[24] H. Dohy,et al. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. , 1990, The New England journal of medicine.
[25] J. Karp,et al. From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. , 1990, The Journal of infectious diseases.
[26] Michael D. Green,et al. GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION , 1989, The Lancet.
[27] B. Löwenberg,et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Gabrilove,et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. , 1988, The New England journal of medicine.
[29] G. Bodey,et al. The emergence of fungi as major hospital pathogens. , 1988, The Journal of hospital infection.
[30] B. Coiffier,et al. Treatment of acute myeloid leukemia in elderly patients. A retrospective study , 1988, Cancer.
[31] W. Stead,et al. Acute pulmonary decompensation due to amphotericin B in the absence of granulocyte transfusions. , 1986, The New England journal of medicine.
[32] G Flandrin,et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.
[33] B. Wong,et al. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. , 1985, Reviews of infectious diseases.
[34] J Whitehead,et al. Group sequential clinical trials with triangular continuation regions. , 1983, Biometrics.
[35] G. Bodey,et al. Fever and infection in leukemic patients. A study of 494 consecutive patients , 1978, Cancer.
[36] D. Alling,et al. NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS. , 1964, Annals of internal medicine.